Atlas Xomics Inc. reported raising $3.9 Million in an initial SEC Form D filing, from an offering of $8 Million
Amount Raised
$3.9 Million
Round Type
Seed
New HavenBiotechnologyQuick answer
AtlasXomics Inc. raised $3.9 Million in a Seed round, dated January 6, 2022. AtlasXomics Inc. is based in New Haven, Connecticut, United States.
- How much did AtlasXomics Inc. raise?
- AtlasXomics Inc. raised $3.9 Million in a Seed round on January 6, 2022.
- Where is AtlasXomics Inc. based and how big is it?
- AtlasXomics Inc. is based in New Haven, Connecticut, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as AtlasXomics Inc. that raised within 45 days of this round, from Fundz verified event records.
- Synthego Corp raised $200M (Funding Round) on February 17, 2022.
- Confluent Medical raised an undisclosed amount on February 17, 2022.
- Seer raised $15M (Series B) on February 17, 2022.
- Neo Medical raised $21M (Funding Round) on February 17, 2022.
- Classiq raised $33M (Funding Round) on February 17, 2022.
- Rubi Laboratories raised $4.5M (Seed) on February 17, 2022.
Who to call at AtlasXomics Inc., and when
A new round usually means AtlasXomics Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AtlasXomics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AtlasXomics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AtlasXomics Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AtlasXomics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
AtlasXomics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.